ClinicalTrials.gg
CompletedNCT00500097Updated Jul 31, 2007

Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training

An interventional study of Digital retina image and direct ophthalmoscopy in Diabetic Retinopathy, sponsored by Ministry of Health, Thailand. Completed at 1 site in Thailand. Open to participants aged 15 Years to 80 Years. Per ClinicalTrials.gov, last updated 2007-07-31.

Sponsored by Ministry of Health, Thailand · Not applicable, Interventional, and Screening

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
840
Allocation
Non-randomized
Ages
15 Years to 80 Years
Sex
All
01

Study summary

The purpose is to assess accuracy of digital retinal image interpretation by technicians and direct ophthalmoscopy by nurses for the determination of diabetic retinopathy severity and the presence of diabetic macular edema for the identification of referrals to ophthalmologists. The results of both screening methods were compared with comprehensive eye examination by ophthalmologists.

Read the detailed description

Diabetic visual disabilities have increasingly become a global concern since a number of diabetic patients are expected to surge dramatically in the coming decade. Essential means to minimize this problem are detecting vision-threatening diabetic retinopathy early in the course of disease and timely interventions by ophthalmologists.

The American Diabetes Association had issued a guideline for the detection and recommended regular comprehensive eye examination as a preferred method. However, it is not likely that there will be ophthalmologists enough to comprehensively examine the surging number of diabetic patients. Other practical screening methods, such as an interpretation of digital retinal images or direct ophthalmoscopy employed by other health care providers, for identifying the retinopathy for referral to ophthalmologists, should minimize this problem.

02

Conditions studied

  • Diabetic Retinopathy

Browse trials for

03

In context

Diabetic Retinopathy

783 studies on the registry are indexed under Diabetic Retinopathy; 145 are open to participants now.

This study's enrollment of 840 is above the median of 80 across 484 interventional studies indexed under Diabetic Retinopathy.

Browse Diabetic Retinopathy studies →

Lead sponsor

Ministry of Health, Thailand is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diabetic patients defined by WHO criteria
  • lived in the geographic area of participated hospitals

Exclusion criteria

Exclusion Criteria:

  • have for receiving mydriatic medications
  • have ocular media not clear enough for making diagnosis by any of the screening equipment
  • have other retina diseases precluded the diagnosis of diabetic retinopathy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Non-randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
840 participants (actual)

Interventions

  • DeviceDigital retina image
  • Devicedirect ophthalmoscopy
  • Procedurecomprehensive eye exam
06

What researchers measure

Primary outcomes

  1. Sensitivity, specificity, kappa coefficient

    Time frame: cross-sectional

07

Study locations

1 site
  • Department of Ophthalmology, Rajavithi Hospital
    Bangkok, 11120, Thailand
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2005 and a completion of Jun 2006. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 11, 2007
First posted
Jul 12, 2007
Start
May 2005
CompletionActual
Jun 2006
Last update
Jul 31, 2007
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 31, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00500097
Lead sponsor
Ministry of Health, Thailand
First posted
Jul 12, 2007
Start date
May 2005
Completion
Jun 2006
Last update
Jul 31, 2007

Study contacts

Paisan Ruamviboonsuk, MD
principal investigator · Department of Ophthalmology, Rajavithi Hospital, Bangkok, Thailand 10400

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion